DE69327432D1 - Heilmittel für wunden und hämorrhoiden - Google Patents

Heilmittel für wunden und hämorrhoiden

Info

Publication number
DE69327432D1
DE69327432D1 DE69327432T DE69327432T DE69327432D1 DE 69327432 D1 DE69327432 D1 DE 69327432D1 DE 69327432 T DE69327432 T DE 69327432T DE 69327432 T DE69327432 T DE 69327432T DE 69327432 D1 DE69327432 D1 DE 69327432D1
Authority
DE
Germany
Prior art keywords
wounds
hemorrhoid
medicine
prostaglandin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327432T
Other languages
English (en)
Other versions
DE69327432T2 (de
Inventor
Makoto Okumura
Toshiaki Cent Research L Okuda
Tsutomu Nakamura
Motoyuki Yamija
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Kaken Pharmaceutical Co Ltd
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Toray Industries Inc filed Critical Kaken Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69327432D1 publication Critical patent/DE69327432D1/de
Publication of DE69327432T2 publication Critical patent/DE69327432T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69327432T 1992-02-07 1993-02-05 Heilmittel für wunden und hämorrhoiden Expired - Fee Related DE69327432T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2280892 1992-02-07
JP18986792 1992-06-24
PCT/JP1993/000151 WO1993015739A1 (en) 1992-02-07 1993-02-05 Remedy for wound or hemorrhoid

Publications (2)

Publication Number Publication Date
DE69327432D1 true DE69327432D1 (de) 2000-02-03
DE69327432T2 DE69327432T2 (de) 2000-05-18

Family

ID=26360087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327432T Expired - Fee Related DE69327432T2 (de) 1992-02-07 1993-02-05 Heilmittel für wunden und hämorrhoiden

Country Status (8)

Country Link
US (3) US5403867A (de)
EP (1) EP0583482B1 (de)
JP (1) JP3209427B2 (de)
AT (1) ATE188119T1 (de)
CA (1) CA2107669C (de)
DE (1) DE69327432T2 (de)
TW (1) TW234691B (de)
WO (1) WO1993015739A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
JP3209427B2 (ja) * 1992-02-07 2001-09-17 科研製薬株式会社 創傷または痔疾治療剤
RO115498B1 (ro) * 1993-10-29 2000-03-30 Univ Boston Metoda de tratament a neoplasmului
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
EP0761225A4 (de) * 1994-06-02 2002-07-24 Teijin Ltd Pharmazeutisches präparat zur behandlung von peripheren durchblutungsstörungen
AU713461B2 (en) * 1994-11-17 1999-12-02 Toray Industries, Inc. Preparation for percutaneous absorption
JP4062743B2 (ja) * 1995-02-27 2008-03-19 東レ株式会社 「肺性心治療剤」
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5869059A (en) * 1996-01-16 1999-02-09 Mon's Tea Partnership Herbal composition for hemorrhoid treatment
AU774861B2 (en) * 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
CN100408039C (zh) * 2002-08-09 2008-08-06 大正制药株式会社 止痒剂
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
MXPA05010552A (es) 2003-04-02 2005-11-23 Nexmed Holdings Inc Composiciones de prostaglandina y su uso para el tratamiento de vasoespasmos.
JP4157889B2 (ja) * 2003-06-25 2008-10-01 有限会社 循環器研究所 性交機能改善用外用製剤
GB0524103D0 (en) * 2005-11-26 2006-01-04 Medical Res Council Healing
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (de) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
WO2014164886A1 (en) * 2013-03-13 2014-10-09 Allergan, Inc. Prostanoid receptor agonist compounds and their use
KR20220034736A (ko) 2019-05-31 2022-03-18 비락타 서브시디어리 인크. 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK142235B (da) * 1974-12-20 1980-09-29 Yamanouchi Pharma Co Ltd Analogifremgangsmåde til fremstilling af 20-alkoxy-16-methyl-prostadiensyre-derivater.
US4025645A (en) * 1976-01-27 1977-05-24 Jelenko Iii Carl Non-steroid topical agent for alleviating inflammation in mammals
GB1595056A (en) * 1976-10-12 1981-08-05 Wellcome Found Pharmaceutical combination
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
DE3162659D1 (en) * 1980-07-22 1984-04-19 Ono Pharmaceutical Co 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof
DE3631169A1 (de) * 1986-09-11 1988-03-24 Schering Ag Prostacyclinderivate enthaltende mittel fuer die topische anwendung
US5401768A (en) * 1987-10-16 1995-03-28 Toray Industries, Inc. 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2, derivative, manufacturing process thereof and its use
JPH0311017A (ja) * 1989-06-06 1991-01-18 Green Cross Corp:The プロスタグランジンｅ↓１含有薬剤組成物
EP0503887B1 (de) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
JP3209427B2 (ja) * 1992-02-07 2001-09-17 科研製薬株式会社 創傷または痔疾治療剤
WO1994017806A1 (en) * 1993-02-03 1994-08-18 Teijin Limited Dermatologic preparation composition containing prostacyclin as active ingredient

Also Published As

Publication number Publication date
EP0583482A4 (de) 1995-05-03
WO1993015739A1 (en) 1993-08-19
DE69327432T2 (de) 2000-05-18
EP0583482A1 (de) 1994-02-23
JP3209427B2 (ja) 2001-09-17
ATE188119T1 (de) 2000-01-15
CA2107669C (en) 2004-06-01
CA2107669A1 (en) 1993-08-08
EP0583482B1 (de) 1999-12-29
US5403867A (en) 1995-04-04
US5679707A (en) 1997-10-21
TW234691B (de) 1994-11-21
US5852050A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
AU549481B2 (en) Hair growing agent
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
KR920019342A (ko) 골질환 치료제
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2159591T3 (es) Composicion de liberacion controlada.
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE173627T1 (de) Medizinische zusammensetzung
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
NO895220D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
AU3401093A (en) Therapeutic agent for threatened abortion
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
NO890724L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом
AU4246189A (en) Medicament for the treatment of diseases caused by retroviruses
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TORAY INDUSTRIES, INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee